title: Hypochlorous acid induced activation of human neutrophil and gingival crevicular fluid collagenase can be inhibited by ascorbate.
abstract: Interstitial collagenase either obtained from human neutrophils by phorbol myristate acetate (PMA) induced degranulation or isolated from human gingival crevicular fluid was found to be activated by addition of an oxidative agent, hypochlorous acid (HOCl). Collagenase released by PMA stimulated neutrophils was completely in latent form but underwent partial autoactivation during 16 h incubation at 22 degrees C in the presence of soy bean trypsin inhibitor. The partial autoactivation was potentiated to complete activation of released collagenase after addition of exogenous HOCl. Ascorbate prevented this activation of neutrophil collagenase. Isolated human gingival crevicular fluid collagenase represented an apparent Mr of 70 kD in completely latent form, whereas 70/54 kD enzyme species were detected for partially autoactive form of the enzyme. Western blot analysis of gingival crevicular fluid using a polyclonal antibody raised against purified human neutrophil collagenase revealed the same 70/54 kD molecular forms of the enzyme. The latent gingival crevicular fluid collagenase was also activated by HOCl and this activation could be prevented by ascorbate. Activation of the 70 kD latent collagenase by HOCl as well as by other non-proteolytic activators such as an organomercurial compound (phenylmercuric chloride) and a gold(I) compound (gold thioglucose) was not associated with detectable changes in apparent Mr, whereas trypsin activation resulted in fragmentation of 70 kD enzyme to 54 kD species. Our results provide further evidence for the neutrophil origin of gingival crevicular fluid collagenase and suggest that, in addition to proteolytic activation, oxidative and antioxidative agents seem to be able to regulate neutrophil collagenase activity.
authors.affiliation: Department of Periodontology, University of Helsinki, Finland.
authors.forename: K
authors.initials: K
authors.lastname: Suomalainen
authors.forename: T
authors.initials: T
authors.lastname: Sorsa
authors.forename: O
authors.initials: O
authors.lastname: Lindy
authors.forename: H
authors.initials: H
authors.lastname: Saari
authors.forename: Y T
authors.initials: YT
authors.lastname: Konttinen
authors.forename: V J
authors.initials: VJ
authors.lastname: Uitto
mesh_terms: D001205:Ascorbic Acid / Q000494:pharmacology*; D002918:Chymotrypsin / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D005883:Gingival Crevicular Fluid / Q000201:enzymology*; D006801:Humans; D006997:Hypochlorous Acid / Q000494:pharmacology*; D003012:Microbial Collagenase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009504:Neutrophils / Q000187:drug effects / Q000201:enzymology*; D010084:Oxidation-Reduction; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
chemical_list: D006997:Hypochlorous Acid; D002918:Chymotrypsin; D014357:Trypsin; D003012:Microbial Collagenase; D013755:Tetradecanoylphorbol Acetate; D001205:Ascorbic Acid